GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SanBio Co Ltd (TSE:4592) » Definitions » Short-Term Debt

SanBio Co (TSE:4592) Short-Term Debt : 円268.00 Mil (As of Jan. 2024)


View and export this data going back to 2015. Start your Free Trial

What is SanBio Co Short-Term Debt?

SanBio Co's Short-Term Debt for the quarter that ended in Jan. 2024 was 円268.00 Mil.

SanBio Co's quarterly Short-Term Debt stayed the same from Jul. 2023 (円268.00 Mil) to Oct. 2023 (円268.00 Mil) and stayed the same from Oct. 2023 (円268.00 Mil) to Jan. 2024 (円268.00 Mil).

SanBio Co's annual Short-Term Debt declined from Jan. 2022 (円512.50 Mil) to Jan. 2023 (円268.00 Mil) but then stayed the same from Jan. 2023 (円268.00 Mil) to Jan. 2024 (円268.00 Mil).


SanBio Co Short-Term Debt Historical Data

The historical data trend for SanBio Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SanBio Co Short-Term Debt Chart

SanBio Co Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 500.00 1,475.00 512.50 268.00 268.00

SanBio Co Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 268.00 268.00 268.00 268.00 268.00

SanBio Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


SanBio Co Short-Term Debt Related Terms

Thank you for viewing the detailed overview of SanBio Co's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


SanBio Co (TSE:4592) Business Description

Traded in Other Exchanges
Address
8-1 Street Luke Tower 32nd Floor, Akashi-cho, Chuo-ku, Tokyo, JPN, 104-0044
SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.

SanBio Co (TSE:4592) Headlines

No Headlines